Article

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung…

BioMed Research International · 2020 · Jing Li, author Hongqi Li, author Yingjie Wang, author Junyang Liu, author Xuan Wang, author Haifeng Pang, author Dongshu Chang, author Yupeng Di, author Gang Ren, author Ping Li, author Yong Wang, author Chen Liu, author Xiao Chen, author Xiaoli Kang, author Tingyi Xia, author Noriyoshi Sawabata, Academic Editor

Key facts

Title Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation
First author Jing Li, author Hongqi Li, author Yingjie Wang, author Junyang Liu, author Xuan Wang, author Haifeng Pang, author Dongshu Chang, author Yupeng Di, author Gang Ren, author Ping Li, author Yong Wang, author Chen Liu, author Xiao Chen, author Xiaoli Kang, author Tingyi Xia, author Noriyoshi Sawabata, Academic Editor
Journal BioMed Research International
Published Mar 12, 2020
DOI 10.1155/2020/9168424
Devices mentioned K042739, K121934, K171837, K183037, K190178
Product codes mentioned IYE, MUJ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature